These sites give comprehensive information on cytogenetics of tumours, with a search engine that allows you to search by tumour type of cytogenetic aberration: http://cgap.nci.nih.gov/Chromosomes/Mitelman , http://amba.charite.de/cgh and http://www.progenetix.net.
Sarcomas:
Tumour |
Chromosomal abnormality |
Fusion transcript |
this translocation has also been reported in: |
||
t(11;22)(q24;q12)1 |
EWS-FLI11 |
two polyphenotypic tumours and two rhabdomyosarcomas20 |
|||
t(21;22)(q22;q12)2 |
EWS-ERG2 |
||||
t(7;22)(p22;q12)3 |
EWS-ETV13 |
||||
t(17;22)(q12;q12) |
EWS-E1AF4 |
||||
t(2;22)(q33;q12)5 |
EWS-FEV5 |
||||
t(11;22)(p13;q12)6 |
EWS-WT16 |
||||
t(21;22)(q22;q12) |
EWS-ERG7 |
||||
t(X;18)(p11.23;q11)8,9 |
SYT-SSX1 |
||||
t(X;18)(p11.21;q11)8,9 |
SYT-SSX2 |
||||
Alveolar rhabdomyosarcoma |
t(2;13)(q35;q14)10,11 |
PAX3-FKHR10 (a.k.a. PAX3-ALV11) |
|||
t(1;13)(p36;q14)12 |
PAX7-FKHR12 |
||||
2p2318 |
ALK18 |
||||
der(17), t(X;17)(p11;q25) |
TFE3/ASPL (a.k.a. ASP-SCR1, RCC17) |
||||
t(12;22)(q13;q12)19 |
ATF1-EWS19 |
||||
t(12;16)(q13;p11)13,14 |
TLS/FUS-CHOP13,14 |
||||
t(12;22)(q13;q12)15 |
EWS-CHOP15 |
||||
t(9;22)(q22;q12)19 |
TEC-EWS19 |
||||
Low-grade fibromyxoid sarcoma |
t(7;16)(q33;p11)19 |
FUS-CREB3L219 |
|||
t(17;22)(q22;13)19 |
COL1A1-PDGFB19 |
||||
t(2;19)(p23;q13.1)19 |
ALK-TPM419 |
||||
t(1;2)(q22-23;p23)19 |
TPM3-ALK19 |
||||
Infantile fibrosarcoma |
t(12;15)(p13;q25)19 |
ETV6-NTRK319 |
|||
Congenital fibrosarcoma and mesoblastic nephroma |
t(12;15)(p13;q25)16,17 |
ETV6-NTRK316,17 |
|||
Some sarcomas show complex karyotypes and non-specific alterations, often in association with p53 mutations19:
High grade pleomorphic sarcoma in adults |
||
Osteosarcoma |
||
Tumour |
Chromosomal abnormality |
Involved gene |
||
Uterine leiomyoma |
t(12q13-15;x) |
HMG1-C |
||
t(6p21;x) |
HMG1(Y) |
|||
Sporadic lipoma |
t(12q13-15) with chromosomes 1 thro' 7, 10,11,13, 15, 17,21 or X |
HMG1-C |
||
t(6p21;x) |
possibly HMG1(Y) |
|||
Lipoblastoma |
8q |
? |
||
t(11q13;x) |
? |
|||
Fibroadenoma |
t(12q13-15;x) |
HMG1-C |
||
Pleomorphic adenoma |
t(12q13-15;x) |
HMG1-C |
||
t(3;8)(p21;q12) |
PLAG1 |
|||
t(12q13-15;x) |
HMG1-C |
|||
inv(6p21) |
HMG1(Y) |
|||
t(6p21;x) |
HMG1(Y) |
|||
Aggressive angiomyxoma |
t(12q13-15;x) |
HMG1-C |
||
Endometrial polyp |
t(12q13-15;x) |
HMG1-C |
||
t(6p21;x) |
possibly HMG1(Y) |
|||
t(12q13-15;x) |
HMG1-C |
|||
19 Hahn HP, Fletcher CDM. The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis - a realistic approach. Current Diagnsotic Pathology 2005;11:361-370.
This page last revised 27.11.2005.
©SMUHT/PW Bishop